Kewaunee Scientific (NASDAQ:KEQU) Raised to Buy at StockNews.com

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday.

Kewaunee Scientific Trading Down 2.8 %

KEQU opened at $41.31 on Monday. The stock has a market cap of $118.56 million, a PE ratio of 6.63 and a beta of 0.80. The business has a 50 day moving average of $35.74 and a 200-day moving average of $41.98. Kewaunee Scientific has a 52 week low of $17.01 and a 52 week high of $55.62. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last released its earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The firm had revenue of $48.39 million for the quarter.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Ritholtz Wealth Management purchased a new position in shares of Kewaunee Scientific in the 2nd quarter worth about $413,000. Dimensional Fund Advisors LP lifted its stake in shares of Kewaunee Scientific by 3.6% in the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after buying an additional 6,132 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Kewaunee Scientific by 13.4% during the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after buying an additional 10,580 shares during the last quarter. Heron Bay Capital Management bought a new stake in shares of Kewaunee Scientific during the second quarter valued at approximately $252,000. Finally, De Lisle Partners LLP raised its holdings in Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

See Also

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.